Early trial tests 'Magic Mushroom' therapy in groups for trauma
NCT ID NCT07506395
Summary
This early-stage study is testing whether group therapy sessions combined with psilocybin (a compound from 'magic mushrooms') is safe and practical for people with PTSD. The main goal is to see if this approach can reduce the severity of PTSD symptoms. The study will involve 36 participants from specific groups, including veterans, first responders, survivors of sexual violence, and Indigenous people.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PTSD are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.